Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 40 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
MEDIVOL from Pajottegem, company number BE0747694905, closed financial year 2025 with a result of € -298 after tax. For that financial year MEDIVOL recorded a gross margin of € 101,751 and equity of € 233,066. Compared with financial year 2024, the result moved from € 53,022 to € -298. The company made a loss. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 7, 2026.
€ 233,066
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -298
▼ still € 53,022 profit in 2024
Profit after tax over the fiscal year.
€ 21,841
▼ 16% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 113,066.
People and assets in 2025
€ 32,004
▲ 20% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
€ 880,082
▼ 7% vs 2024
€ 71,458 is repaid this year. At this pace the long-term loan is gone in ≈ 12 years.
€ 1,778
▲ 63% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 2,149
▼ 81% vs 2024
Wages, holiday pay and social contributions still to pay. No outstanding taxes.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 95,733 | € 138,663 | € 163,977 | € 101,751 | ▼ 38% |
| Profit after taxes | € 29,234 | € 37,094 | € 53,022 | € -298 | ▼ € 53,321 |
| Equity | € 143,248 | € 180,342 | € 233,365 | € 233,066 | |
| Total debts | € 1,085,803 | € 1,000,982 | € 964,361 | € 885,509 | ▼ 8% |
| Cash | € 27,225 | € 9,548 | € 26,124 | € 21,841 | ▼ 16% |
| Land & buildings | € 1,098,017 | € 1,066,248 | € 1,062,156 | € 1,027,392 | ▼ 3% |
| Retained profit | € 23,248 | € 60,342 | € 113,365 | € 113,066 | |
| Bank debt | € 1,059,612 | € 993,616 | € 950,353 | € 880,082 | ▼ 7% |
| Balance sheet total | € 1,229,051 | € 1,181,324 | € 1,197,726 | € 1,118,575 | ▼ 7% |
Key figures of MEDIVOL, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to MEDIVOL?
What happened at MEDIVOL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 298 (▼ € 53,321 vs 2024). Source: NBB ↗
- New establishment in Pajottegem. KBO
- Start of the company according to the CBE. KBO
In short
From € 29,234 profit in 2022 to € 298 loss in 2025.
Paid € 15,940 in corporate taxes since 2022.
Best year ever: 2024, with € 53,022 profit.
A new publication or filing at MEDIVOL? We notify you, reason included.
Follow MEDIVOLDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of DOKTER VERGAUWEN KARIN, huisarts, "Dr. Annabelle Roobaert BV" comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
MEDIVOLBehind MEDIVOL are Dokter Van Parys Liselore, Huisaarts BV and Dr. Annabelle Roobaert BV. The shares are held by DOKTER VERGAUWEN KARIN, huisarts (18.3%) and "Dr. Annabelle Roobaert BV" (18.3%).
Directors
According to the 2025 annual accounts
Dokter Van Parys Liselore, Huisaarts BV
Director · represented by Liselore Van Parys
Director · represented by Annabelle Roobaert
Shareholders
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Molenstraat 1
1570 Pajottegem
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0747.694.905
- VAT number
- BE 0747.694.905
- Registered office
- Molenstraat 1, 1570 Pajottegem
- Names & denominations
- MEDIVOL
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 28 May 2020
- Peppol
- Active · Active since 24 Nov 2023